Improve patient care and protect your practice with 24-hour turn and 99.8% accuracy.

Our partners molecular testing methods have fundamentally revolutionized microbiological diagnoses. They offer significant advantages over conventional culture-based methods including results that are achieved within hours instead of days and allowing for procedures that are more sensitive and specific.

URINARY TRACT PATHOGEN DETECTION

Lab developed real-time PCR
 solution-based tests detect organisms that cultures miss.

PCR/UTI detection identifies more bacteria and fastidious bacteria than traditional urine cultures. We are proud to offer the following molecular testing services for urinary tract pathogen detection:

• Acinetobacter baumannii Bacterial
• Citrobacter freundii
• Enterobacter aerogense
• Enterobacter cloacae
• Enterococcus faecalis
• Enterococcus faecium
• Escherichia coli
• Klebsiella oxytoca
• Klebsiella pneumoniae
• Morganella Morganii
• Proteus mirabilis
• Proteus vulgaris
• Providencia stuarti
• Psedomonas aeruginosa
• Staphylococcus saprophyticus
• Streptococcus agalactiae
• Candida albicans

RESPIRATORY PATHOGEN (RPP) DETECTION AND COVID

Our process is significantly more rapid in providing results compared to culturing. And, it is extremely useful for confirming rapid Flu and COVID tests.

RPP detection provides rapid diagnosis of bacteremia, particularly for low levels of bacteria in specimens. It’s valuable for detecting specific pathogens that are difficult to culture in vitro or require a long cultivation period. RPP detection is also useful in detecting cases in extra pulmonary specimens which may be missed by smear and/or culture. We use an advanced multiplexed respiratory pathogen panel utilizing multiple molecular hardware platforms. It’s a comprehensive, detailed assay that detects multiple respiratory pathogens simultaneously in a closed-tube, easy–to–use system.

Why respiratory testing matters.

Upper respiratory infections are responsible for many life-threatening illnesses, especially in elderly populations. We offer a multiplexed molecular respiratory pathogen panel developed to broaden and streamline testing for multiple viral and bacterial agents of the upper respiratory tract. The test is performed by nasopharyngeal swab and provides detailed information quickly and accurately.